SE426490B - Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner - Google Patents

Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner

Info

Publication number
SE426490B
SE426490B SE7608265A SE7608265A SE426490B SE 426490 B SE426490 B SE 426490B SE 7608265 A SE7608265 A SE 7608265A SE 7608265 A SE7608265 A SE 7608265A SE 426490 B SE426490 B SE 426490B
Authority
SE
Sweden
Prior art keywords
bensazolylalkyl
piperidines
preparation
analogy procedure
analogy
Prior art date
Application number
SE7608265A
Other languages
English (en)
Swedish (sv)
Other versions
SE7608265L (sv
Inventor
J Vandenberk
L E J Kennis
Der Aa M J M C Van
Heertum A H M T Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/687,139 external-priority patent/US4066772A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7608265L publication Critical patent/SE7608265L/xx
Publication of SE426490B publication Critical patent/SE426490B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7608265A 1975-07-21 1976-07-20 Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner SE426490B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59779375A 1975-07-21 1975-07-21
US05/687,139 US4066772A (en) 1975-07-21 1976-05-17 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
KR7601697A KR810000334B1 (ko) 1975-07-21 1976-07-12 1-(벤즈 아조릴알킬) 피페리딘 유도체의 제조방법

Publications (2)

Publication Number Publication Date
SE7608265L SE7608265L (sv) 1977-01-22
SE426490B true SE426490B (sv) 1983-01-24

Family

ID=27348142

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7608265A SE426490B (sv) 1975-07-21 1976-07-20 Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner
SE8008713A SE435621B (sv) 1975-07-21 1980-12-11 Analogiforfarande for framstellning av 1-(bensimidazolylalkyl)piperidiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8008713A SE435621B (sv) 1975-07-21 1980-12-11 Analogiforfarande for framstellning av 1-(bensimidazolylalkyl)piperidiner

Country Status (25)

Country Link
JP (1) JPS5217475A (hu)
AT (1) AT364358B (hu)
AU (1) AU511027B2 (hu)
BG (1) BG26526A3 (hu)
CA (1) CA1085852A (hu)
CH (1) CH623820A5 (hu)
CS (1) CS202550B2 (hu)
DE (1) DE2632870A1 (hu)
DK (1) DK154950C (hu)
ES (3) ES449740A1 (hu)
FI (1) FI62667C (hu)
GB (1) GB1542514A (hu)
HK (1) HK14180A (hu)
IE (1) IE43496B1 (hu)
IT (1) IT1062614B (hu)
KE (1) KE3215A (hu)
LU (1) LU75354A1 (hu)
MY (1) MY8100017A (hu)
NL (1) NL187442C (hu)
NZ (1) NZ181256A (hu)
PH (1) PH13710A (hu)
PT (1) PT65387B (hu)
RO (1) RO70566A (hu)
SE (2) SE426490B (hu)
YU (1) YU39969B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
JPS6248684A (ja) * 1985-08-26 1987-03-03 Sumitomo Chem Co Ltd 新規なヨ−ドブチロフエノン誘導体およびその製造法
JPS62251313A (ja) * 1986-04-25 1987-11-02 信越ポリマー株式会社 結束装置
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
PA8603801A1 (es) * 2003-05-27 2004-12-16 Janssen Pharmaceutica Nv Derivados de la quinazolina
CA2549869C (en) 2003-12-18 2015-05-05 Janssen Pharmaceutica N.V. Pyrido- and pyrimidopyrimidine derivatives as anti- proliferative agents
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
AU2007274284B2 (en) 2006-07-13 2012-04-26 Janssen Pharmaceutica N.V. Mtki quinazoline derivatives
EP1997805A1 (en) * 2007-06-01 2008-12-03 Commissariat à l'Energie Atomique Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
ES2562218T3 (es) 2007-07-27 2016-03-03 Janssen Pharmaceutica, N.V. Pirrolopirimidinas útiles para el tratamiento de enfermedades proliferativas
RU2488585C2 (ru) 2007-08-31 2013-07-27 Пэдью Фарма Л.П. Замещенные пиперидиновые соединения хиноксалинового типа и их применение
WO2014102594A2 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
CN113995755A (zh) * 2016-02-04 2022-02-01 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (hu) * 1962-06-13
BE633914A (hu) * 1962-06-22
US3629267A (en) * 1968-10-28 1971-12-21 Smith Kline French Lab Benzoheterocyclicalkyl derivatives of 4-(2-keto -1-benzimidazolinyl)-piperidine 4-(2-keto - 1 - benzimidazolinyl) -1 2 3 6 tetrahydropyridine 1 - phenyl - 1 3 8-triazaspiro(4 5)decan - 4 - one and 2 4 9-triazaspiro(5 5)undecan-1 3 5-trione
AU4698672A (en) * 1972-09-22 1972-11-09 Ciba-Geigy Ag Azacycloaliphatic compounds, process for their manufacture and compositions containing them
FR2218100A1 (en) * 1973-02-20 1974-09-13 Janssen Pharmaceutica Nv Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives

Also Published As

Publication number Publication date
FI762086A (hu) 1977-01-22
ES449740A1 (es) 1978-02-16
AT364358B (de) 1981-10-12
HK14180A (en) 1980-03-28
ES461631A1 (es) 1978-12-01
PT65387A (en) 1976-08-01
FI62667B (fi) 1982-10-29
IT1062614B (it) 1984-10-20
JPS5217475A (en) 1977-02-09
GB1542514A (en) 1979-03-21
CS202550B2 (en) 1981-01-30
YU179476A (en) 1983-01-21
JPS6131109B2 (hu) 1986-07-17
DK327576A (da) 1977-01-22
DE2632870A1 (de) 1977-02-10
RO70566A (ro) 1982-10-11
AU511027B2 (en) 1980-07-24
CH623820A5 (en) 1981-06-30
CA1085852A (en) 1980-09-16
DK154950C (da) 1989-05-29
IE43496B1 (en) 1981-03-11
FI62667C (fi) 1983-02-10
DK154950B (da) 1989-01-09
SE435621B (sv) 1984-10-08
IE43496L (en) 1977-01-21
BG26526A3 (bg) 1979-04-12
ATA534776A (de) 1981-03-15
SE7608265L (sv) 1977-01-22
ES461630A1 (es) 1978-06-16
DE2632870C2 (hu) 1989-02-16
MY8100017A (en) 1981-12-31
PT65387B (en) 1978-06-09
YU39969B (en) 1985-06-30
LU75354A1 (hu) 1977-02-28
NZ181256A (en) 1978-04-28
NL187442C (nl) 1991-10-01
SE8008713L (sv) 1980-12-11
NL187442B (nl) 1991-05-01
AU1596476A (en) 1978-01-19
NL7608023A (nl) 1977-01-25
KE3215A (en) 1982-07-09
PH13710A (en) 1980-09-09

Similar Documents

Publication Publication Date Title
SE430335B (sv) Analogiforfarande for framstellning av pyridinyl-pyridinoner
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7610940L (sv) Forfarande for framstellning av benshydrylsulfinylderivat
SE425489B (sv) Analogiforfarande for framstellning av 1,3,4-trisubstituerade 4-fenyl-piperidiner
SE426490B (sv) Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner
SE431872B (sv) Analogiforfarande for framstellning av derivat av 4-pyrimidon
SE417610B (sv) Analogiforfarande for framstellning av 1-bensazolylalkyl-4-substituerade piperidiner
SE442010B (sv) Forfarande for framstellning av aziner
SE425660B (sv) Analogiforfarande for framstellning av 1,4-dihydropyridiner
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE435510B (sv) Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
SE421422B (sv) Analogiforfarande for framstellning av 6-metyl-8beta-isocyanometyl-ergolin
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE428923B (sv) Analogiforfarande for framstellning av 1-metyl-4-(trifluorometyltio-5h-dibenso/a,d/cyklohepten-5-yliden)piperidin
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE423233B (sv) Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE427840B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE7602696L (sv) Forfarande for framstellning av fernissa baserad pa polyesterharts
SE428689B (sv) Forfarande for framstellning av aroyl-fenylnaftalenforeningar
SE435291B (sv) Forfarande for framstellning av 7-acylamino-3(1-(2-sulfaminoetyl)-tetrazol-5-yltiometyl)-3-cefem-4-karbonsyra
SE427558B (sv) Analogiforfarande for framstellning av 7-metoxicefalosporinderivat
SE7605104L (sv) Forfarande for framstellning av fiberboard

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7608265-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7608265-0

Format of ref document f/p: F